Dale Curtis Hogue Jr. - 20 Jan 2024 Form 4 Insider Report for Alaunos Therapeutics, Inc. (TCRT)

Role
Interim CEO, Director
Signature
/s/ Michael Wong, By PoA from Dale Curtis Hogue, Jr.
Issuer symbol
TCRT
Transactions as of
20 Jan 2024
Net transactions value
$0
Form type
4
Filing time
23 Jan 2024, 17:47:51 UTC
Previous filing
03 Jan 2024
Next filing
01 Apr 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCRT Employee Stock Option (right to buy) Award $0 +600,000 $0.000000 600,000 20 Jan 2024 Common Stock 600,000 $0.1200 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 In twelve equal monthly installments measured from January 20, 2024, with the first vesting occurring on February 20, 2024, subject to the Reporting Person's continued service through each such date.